Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery
Open Access
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (4) , 643-650
- https://doi.org/10.1038/sj.gt.3300843
Abstract
Self-assembling polycation/DNA complexes represent a promising synthetic vector for gene delivery. However, despite considerable versatility and transfectional activity in vitro, such materials are quickly eliminated from the bloodstream following intravenous injection (plasma α half-life typically less than 5 min). For targeted systemic delivery a more prolonged plasma circulation of the vector is essential. Here we have examined factors contributing to rapid elimination of poly(L-lysine) (pLL)/DNA complexes from the bloodstream, and implicate the binding of proteins to the polyelectrolyte complexes as a likely cause for their blood clearance. pLL/DNA complexes reisolated from serum associate with several proteins, depending on their net charge, although the major band on SDS-PAGE co-migrates with albumin. Serum albumin binds to pLL/DNA complexes in vitro, forming a ternary pLL/DNA/albumin complex which regains some ethidium bromide fluorescence and fails to move during agarose electrophoresis. Albumin also causes increased turbidity of complexes, and reduces their zeta potential to the same level (−16 mV) as is measured in serum. We propose that rapid plasma elimination of polycation/DNA complexes results from their binding serum albumin and other proteins, perhaps due to aggregation and phagocytic capture or accumulation of the ternary complexes in fine capillary beds.Keywords
This publication has 19 references indexed in Scilit:
- Chloroquine and amphipathic peptide helices show synergistic transfection in vitroGene Therapy, 1998
- Synthetic polymers for vectorial delivery of DNA: characterisation of polymer-DNA complexes by photon correlation spectroscopy and stability to nuclease degradation and disruption by polyanions in vitroJournal of Controlled Release, 1997
- In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexesGene Therapy, 1997
- Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administrationGene Therapy, 1997
- Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-PolymersHuman Gene Therapy, 1996
- Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene DeliveryHuman Gene Therapy, 1996
- Influence of dose on liposome clearance: critical role of blood proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on BiodistributionPharmaceutical Research, 1996
- Less Hype, More Biology Needed for Gene TherapyScience, 1995
- Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriersNucleic Acids Research, 1994